By KAI ICHINO/ Staff Writer
September 28, 2021 at 18:10 JST
Sotrovimab, a COVID-19 drug developed by GlaxoSmithKline K.K. (Provided by GlaxoSmithKline K.K.)
The health ministry granted fast-track approval for a neutralizing antibody on Sept. 27, making it the second COVID-19 treatment available in Japan for patients with mild symptoms. [Read More]
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
A peek through the music industry’s curtain at the producers who harnessed social media to help their idols go global.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series about Japanese-Americans and their memories of World War II
